Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density

Inclusion Criteria

• •1. Each subject must have participated or is currently participating in study 3068A1 301, and must satisfy all of the following criteria
• •2. Has completed 24 months of treatment.
• •3. Had a mammogram at the baseline visit and at the month 24 visit, and both are original films that are technically acceptable for reading.
• •4. Was less than or equal to 62 years of age at the time of study randomization in the primary study.
• •5. Was at least 80% compliant with test article administration.
• •6. Did not take any medications 6 months prior to screening in the primary study or during the first 24 months of the study that could cause a change in breast density.
• •8. Was enrolled at a clinical site that is still participating in the primary study.